Armata Pharmaceuticals, Inc. - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 30, 2016

Attached files

file filename
10-K - FORM 10-K - Armata Pharmaceuticals, Inc.v429366_10k.htm
EX-4.12 - EXHIBIT 4.12 - Armata Pharmaceuticals, Inc.v429366_ex4-12.htm
EX-31.2 - EXHIBIT 31.2 - Armata Pharmaceuticals, Inc.v429366_ex31-2.htm
EX-32.2 - EXHIBIT 32.2 - Armata Pharmaceuticals, Inc.v429366_ex32-2.htm
EX-4.13 - EXHIBIT 4.13 - Armata Pharmaceuticals, Inc.v429366_ex4-13.htm
EX-31.1 - EXHIBIT 31.1 - Armata Pharmaceuticals, Inc.v429366_ex31-1.htm
EX-99.2 - EXHIBIT 99.2 - Armata Pharmaceuticals, Inc.v429366_ex99-2.htm
EX-21.1 - EXHIBIT 21.1 - Armata Pharmaceuticals, Inc.v429366_ex21-1.htm
EX-4.11 - EXHIBIT 4.11 - Armata Pharmaceuticals, Inc.v429366_ex4-11.htm
EX-99.1 - EXHIBIT 99.1 - Armata Pharmaceuticals, Inc.v429366_ex99-1.htm
EX-32.1 - EXHIBIT 32.1 - Armata Pharmaceuticals, Inc.v429366_ex32-1.htm
EX-10.26 - EXHIBIT 10.26 - Armata Pharmaceuticals, Inc.v429366_ex10-26.htm
EX-10.23 - EXHIBIT 10.23 - Armata Pharmaceuticals, Inc.v429366_ex10-23.htm
EX-10.24 - EXHIBIT 10.24 - Armata Pharmaceuticals, Inc.v429366_ex10-24.htm
EX-10.25 - EXHIBIT 10.25 - Armata Pharmaceuticals, Inc.v429366_ex10-25.htm
EX-10.16 - EXHIBIT 10.16 - Armata Pharmaceuticals, Inc.v429366_ex10-16.htm

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-203455), pertaining to the 2012 Stock Incentive Plan and 2013 Stock Incentive Plan of AmpliPhi Biosciences Corporation, of our report dated March 30, 2016, with respect to the consolidated financial statements of AmpliPhi Biosciences Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2015.

 

/s/ Ernst & Young LLP

 

Richmond, Virginia

March 30, 2016

 

 

 

Armata Pharmaceuticals, Inc. Reports